RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @EricTopol: A really smart editorial on the vaccines @NatureBiotech https://t.co/WFWf3LqHVp "Public health messaging during the epidemi…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @SecretLabMS: "Ironically, the RNA and viral vector vaccines that are furthest along in clinical development are the least suitable for…
RT @SecretLabMS: "Ironically, the RNA and viral vector vaccines that are furthest along in clinical development are the least suitable for…
RT @SecretLabMS: "Ironically, the RNA and viral vector vaccines that are furthest along in clinical development are the least suitable for…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @tmprowell: Manufacturing, efficient distribution, & assurance of public trust in #COVID19 vaccines will be key to timely control of the…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
Preparing for the vaccine https://t.co/eKwAgo6i8Y
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
Manufacturing, efficient distribution, & assurance of public trust in #COVID19 vaccines will be key to timely control of the #coronavirus #pandemic. We still need to #MaskUp nationwide until a majority of the population is immune.
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
Wish we talked more about how difficult this vaccine is to store and transport.
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
can do, will do, science/technology/gov backing
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
"vaccines should be positioned alongside hand-washing, social distancing, masking and insolation as a part of the problem of pandemic solution, not a panacea to immediately end it." No es tiempo de relajar, es tiempo de seguir adoptando todas las medidas p
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
Iespējams, būs vakcīnu deficīts...
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
요즘 백신에 관심 진짜 많구 애초에 면역학 전공하려고 생각 중이라 ,, 읽어봐야지 제발 읽으라고 그만 놀고 읽으라고
"Ironically, the RNA and viral vector vaccines that are furthest along in clinical development are the least suitable for large-scale manufacture, storage and distribution"
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make enough vaccine not for a few million people, but for hundreds of millions https://t.co/LW3oSpHD4W https://t.co/4dafbtrVtg
Preparing for the vaccine. Clear and consistent messaging on COVID-19 vaccine rollout will be key to building public trust and managing expectations. Read more: https://t.co/eHDIPrb9G6 #BGI #COVID19 #health #omicsforall https://t.co/JFttzTPxoP
Some really interesting context for today’s vaccine announcement.
It's a tricky vaccine in terms of handling - it needs to be stored at –70 °C - so the rollout will be not be straightforward - this is an excellent summation of the complexities of vaccine manufacturing & distribution: https://t.co/S7KpxGBwD5
The first thing should be which company will provide effective vaccine. Don’t test its protection in people.
RT @GGRecchia: Preparing for the Covid-19 #vaccine @nature Biotechnology https://t.co/w4y9xQdUOs https://t.co/xPjq8GCvje
An interesting read about the challenges that will lay ahead once a #COVID19 vaccine is approved.
I think this is right: approval of a vaccine is just the beginning, how to get it distributed & how to ensure ppl can get two doses on a timely & orderly way isn’t a smaller challenge.
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @GGRecchia: Preparing for the Covid-19 #vaccine @nature Biotechnology https://t.co/w4y9xQdUOs https://t.co/xPjq8GCvje
Preparing for the Covid-19 #vaccine @nature Biotechnology https://t.co/w4y9xQdUOs https://t.co/xPjq8GCvje
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
Γιατί το θέμα δεν είναι μόνο να βγει το εμβόλιο αλλά και σε πόσους ανθρώπους θα διατεθεί. Η φάση είναι game changer.
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
Preparing for the vaccine | Nature Biotechnology https://t.co/qf7PTCGLYd
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make enough vaccine not for a few million people, but for hundreds of millions https://t.co/LW3oSpHD4W https://t.co/GUwBDEvaYK
#COVID19 Impfstoffe werden helfen, aber kein Wundermittel sein, um die Pandemie unmittelbar zu beenden. Eine realistische Kommunikation darüber ist nötig, um Vertrauen in Präventionsmaßnahmen zu stärken. (Key Message des Editorials auf Deutsch)
RT @NatureBiotech: As approval of the first #COVID19 vaccine draws closer, attention is shifting to an unprecedented challenge: how to make…
RT @EricTopol: A really smart editorial on the vaccines @NatureBiotech https://t.co/WFWf3LqHVp "Public health messaging during the epidemi…
RT @dgbracewell: Nice piece outlining some of the substantial manufacturing and supply issues ahead for COVID-19 vaccines @vaxhub https://t…
Preparing for the vaccine https://t.co/xQoGh8XVVJ
RT @NatalieDakers: Agreed. Communication, communication, communication around the expectations for vaccines and their distribution is criti…
RT @NatalieDakers: Agreed. Communication, communication, communication around the expectations for vaccines and their distribution is criti…
Agreed. Communication, communication, communication around the expectations for vaccines and their distribution is critical!
Preparing for the vaccine https://t.co/xuDIQDNxNs